Psychological therapies for major depressive disorder and prolonged grief in bereaved adults

Research output: Contribution to journalArticle

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness of CBT (e.g. cognitive therapy, cognitive behavioural therapy, rational emotive behaviour therapy, prolonged grief CBT) compared with non-CBT therapies (e.g. psychodynamic, humanistic, family or systemic therapies) for treating people with bereavement-related MDD or PGD. To assess the effectiveness of CBT compared with usual care or waiting list for treating people with bereavement-related MDD or PGD. To assess the effectiveness of CBT compared with pharmacological interventions (e.g. antidepressant medications and other drug therapies used explicitly for treating depressive disorders (Sadock 2009)) for treating people with bereavement-related MDD or PGD.Copyright © 2018 The Cochrane Collaboration.
LanguageEnglish
PagesCD013237
JournalCochrane Database of Systematic Reviews
Volume2018
Issue number12
DOIs
Publication statusPublished - 20 Dec 2018

Fingerprint

Prostaglandins D
Bereavement
Grief
Major Depressive Disorder
Cognitive Therapy
Psychology
Waiting Lists
Behavior Therapy
Depressive Disorder
Antidepressive Agents
Therapeutics
Pharmacology
Drug Therapy

Keywords

  • *bereavement support
  • *emotional disorder/th [Therapy]
  • *major depression/th [Therapy]
  • *prolonged grief disorder/th [Therapy]
  • *psychotherapy
  • article
  • clinical effectiveness
  • clinical protocol
  • cognitive behavioral therapy
  • evidence based medicine
  • human
  • intermethod comparison
  • mental disease assessment
  • outcome assessment
  • priority journal
  • rational emotive behavior therapy
  • social stigma
  • treatment response

Cite this

@article{ac59bf81a02e41189af73d09767c1c84,
title = "Psychological therapies for major depressive disorder and prolonged grief in bereaved adults",
abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness of CBT (e.g. cognitive therapy, cognitive behavioural therapy, rational emotive behaviour therapy, prolonged grief CBT) compared with non-CBT therapies (e.g. psychodynamic, humanistic, family or systemic therapies) for treating people with bereavement-related MDD or PGD. To assess the effectiveness of CBT compared with usual care or waiting list for treating people with bereavement-related MDD or PGD. To assess the effectiveness of CBT compared with pharmacological interventions (e.g. antidepressant medications and other drug therapies used explicitly for treating depressive disorders (Sadock 2009)) for treating people with bereavement-related MDD or PGD.Copyright {\circledC} 2018 The Cochrane Collaboration.",
keywords = "*bereavement support, *emotional disorder/th [Therapy], *major depression/th [Therapy], *prolonged grief disorder/th [Therapy], *psychotherapy, article, clinical effectiveness, clinical protocol, cognitive behavioral therapy, evidence based medicine, human, intermethod comparison, mental disease assessment, outcome assessment, priority journal, rational emotive behavior therapy, social stigma, treatment response",
author = "Roulston A. and Clarke M.J. and Donnelly M. and Candy B. and Mcgaughey J. and Keegan O. and Duffy M.",
year = "2018",
month = "12",
day = "20",
doi = "10.1002/14651858.CD013237",
language = "English",
volume = "2018",
pages = "CD013237",
journal = "Cochrane database of systematic reviews (Online)",
issn = "1469-493X",
publisher = "John Wiley and Sons Ltd",
number = "12",

}

TY - JOUR

T1 - Psychological therapies for major depressive disorder and prolonged grief in bereaved adults

AU - A., Roulston

AU - M.J., Clarke

AU - M., Donnelly

AU - B., Candy

AU - J., Mcgaughey

AU - O., Keegan

AU - M., Duffy

PY - 2018/12/20

Y1 - 2018/12/20

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness of CBT (e.g. cognitive therapy, cognitive behavioural therapy, rational emotive behaviour therapy, prolonged grief CBT) compared with non-CBT therapies (e.g. psychodynamic, humanistic, family or systemic therapies) for treating people with bereavement-related MDD or PGD. To assess the effectiveness of CBT compared with usual care or waiting list for treating people with bereavement-related MDD or PGD. To assess the effectiveness of CBT compared with pharmacological interventions (e.g. antidepressant medications and other drug therapies used explicitly for treating depressive disorders (Sadock 2009)) for treating people with bereavement-related MDD or PGD.Copyright © 2018 The Cochrane Collaboration.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness of CBT (e.g. cognitive therapy, cognitive behavioural therapy, rational emotive behaviour therapy, prolonged grief CBT) compared with non-CBT therapies (e.g. psychodynamic, humanistic, family or systemic therapies) for treating people with bereavement-related MDD or PGD. To assess the effectiveness of CBT compared with usual care or waiting list for treating people with bereavement-related MDD or PGD. To assess the effectiveness of CBT compared with pharmacological interventions (e.g. antidepressant medications and other drug therapies used explicitly for treating depressive disorders (Sadock 2009)) for treating people with bereavement-related MDD or PGD.Copyright © 2018 The Cochrane Collaboration.

KW - bereavement support

KW - emotional disorder/th [Therapy]

KW - major depression/th [Therapy]

KW - prolonged grief disorder/th [Therapy]

KW - psychotherapy

KW - article

KW - clinical effectiveness

KW - clinical protocol

KW - cognitive behavioral therapy

KW - evidence based medicine

KW - human

KW - intermethod comparison

KW - mental disease assessment

KW - outcome assessment

KW - priority journal

KW - rational emotive behavior therapy

KW - social stigma

KW - treatment response

U2 - 10.1002/14651858.CD013237

DO - 10.1002/14651858.CD013237

M3 - Article

VL - 2018

SP - CD013237

JO - Cochrane database of systematic reviews (Online)

T2 - Cochrane database of systematic reviews (Online)

JF - Cochrane database of systematic reviews (Online)

SN - 1469-493X

IS - 12

ER -